Cheaper Breast Cancer Drug Does Well in Clinical Trial
It has similar effectiveness, safety compared to Herceptin for HER2-positive diseaseContinue Reading
It has similar effectiveness, safety compared to Herceptin for HER2-positive diseaseContinue Reading
Experimental approach doubles time to disease progression, experts findContinue Reading
But better tools needed to support their long-term recovery, experts sayContinue Reading
Six-week class reduced fear of recurrence, fatigue and anxiety, researchers reportContinue Reading
Study found most benefit seen in those taking the drug before their cancer diagnosisContinue Reading
Injectable virus appears to extend lives of glioblastoma patientsContinue Reading
Injectable virus appears to extend lives of glioblastoma patientsContinue Reading
Survey finds wide support in all regions to raise cutoff to age 19 or olderContinue Reading
‘Vaping’ only replaces tobacco use for a small group of people, study findsContinue Reading
Rodents exposed to phone radiation actually lived longer than unexposed animals, reviewers point outContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.